A Study to Assess the Relative Bioavailability And Food Effect of a Tablet Formulation of GDC-0276 in Healthy Participants
Status:
Withdrawn
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This open-label, randomized, 4-way crossover study in healthy participants will determine the
relative bioavailability of the tablet formulation relative to the capsule formulation and
the effect of a high-fat and low-fat meal on the relative bioavailability of the tablet
formulation.